For example, in our review, the infliximab-treated FMF case (Table 1) achieved complete remission of articular symptoms, reinforcing the hypothesis of a TNF-mediated inflammatory pathway specifically driving chronic joint manifestations, distinct from the IL-1-induced febrile phenotype. This evidence concerns the gene TNF and familial Mediterranean fever.